Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Malek Al-Hawwas to Humans

This is a "connection" page, showing publications Malek Al-Hawwas has written about Humans.

 
Connection Strength
  
 
 
0.179
  
  1. Kadavath S, Ayan M, Al-Hawwas M. Dynamic Systolic Compression of the Left Anterior Descending Coronary Artery as the First Clue of Postinfarction Left Ventricular Pseudoaneurysm. Can J Cardiol. 2019 10; 35(10):1419.e9-1419.e11.
    View in: PubMed
    Score: 0.028
  2. Al-Hawwas M, Tsitlakidou D, Gupta N, Iliescu C, Cilingiroglu M, Marmagkiolis K. Acute Coronary Syndrome Management in Cancer Patients. Curr Oncol Rep. 2018 08 22; 20(10):78.
    View in: PubMed
    Score: 0.026
  3. Al-Hawwas M, Marmagkiolis K, Mehta JL. The Impact of Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement on Left Ventricular Remodeling. Am J Cardiol. 2017 Oct 01; 120(7):1198-1202.
    View in: PubMed
    Score: 0.024
  4. Uretsky BF, Agarwal SK, Vallurupalli S, Al-Hawwas M, Miller K, Biscaglia S, Hakeem A. Trans-Stent FFR Gradient as a Modifiable Integrant in Predicting Long-Term Target Vessel Failure. JACC Cardiovasc Interv. 2022 11 14; 15(21):2192-2202.
    View in: PubMed
    Score: 0.009
  5. Salah HM, Almaddah N, Xu J, Al-Hawwas M, Agarwal SK, Uretsky BF, Dhar G, Al'Aref SJ. Gender Differences and Outcomes of Hypoattenuated Leaflet Thickening (HALT) Following Transcatheter Aortic Valve Replacement: A Meta-analysis of Randomized and Cohort Studies. Curr Probl Cardiol. 2023 Jul; 48(7):101155.
    View in: PubMed
    Score: 0.008
  6. Salah HM, Al'Aref SJ, Khan MS, Al-Hawwas M, Vallurupalli S, Mehta JL, Mounsey JP, Greene SJ, McGuire DK, Lopes RD, Fudim M. Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022 02 05; 21(1):20.
    View in: PubMed
    Score: 0.008
  7. Vallurupalli S, Salehi N, Agarwal S, Hasan R, Hassan A, Siraj A, Madmani ME, Rafeedheen R, Ayan M, Al-Hawwas M, Hakeem A, Uretsky BF. Exhaustion of coronary vasodilatory reserve in the resting state: Clinical characteristics and long-term outcomes after intervention. Catheter Cardiovasc Interv. 2021 11 15; 98(6):1021-1026.
    View in: PubMed
    Score: 0.008
  8. Hakeem A, Hou L, Shah K, Agarwal SK, Almomani A, Edupuganti M, Kasula S, Pothineni NV, Al-Hawwas M, Miller K, Zakir R, Ghosh B, Uretsky BF. Derivation and validation of Pd/Pa in the assessment of residual ischemia post-intervention: A prospective all-comer registry. Catheter Cardiovasc Interv. 2022 02; 99(3):714-722.
    View in: PubMed
    Score: 0.008
  9. Agarwal SK, Hakeem A, Hasan R, Ayan M, Siraj A, Madmani ME, Rafeedheen R, Salehi N, Kasula S, Hacioglu Y, Miller K, Vallurupalli S, Al-Hawwas M, Uretsky BF. Fractional Flow Reserve After Functionally Optimized Coronary Intervention Predicts Very Long-Term Outcomes. JACC Cardiovasc Interv. 2021 02 08; 14(3):355-356.
    View in: PubMed
    Score: 0.008
  10. Salah HM, Al'Aref SJ, Khan MS, Al-Hawwas M, Vallurupalli S, Mehta JL, Mounsey JP, Greene SJ, McGuire DK, Lopes RD, Fudim M. Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update. Am Heart J. 2021 03; 233:86-91.
    View in: PubMed
    Score: 0.008
  11. Salah HM, Al'Aref SJ, Khan MS, Al-Hawwas M, Vallurupalli S, Mehta JL, Mounsey JP, Greene SJ, McGuire DK, Lopes RD, Fudim M. Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials. Am Heart J. 2021 02; 232:10-22.
    View in: PubMed
    Score: 0.008
  12. Hassan A, Uretsky BF, Vargas Estrada AM, Hassan R, Al-Hawwas M, Agarwal SK. Systematic review of the evaluation and management of coronary pseudoaneurysm after stent implantation. Catheter Cardiovasc Interv. 2021 07 01; 98(1):107-116.
    View in: PubMed
    Score: 0.008
  13. Uretsky BF, Agarwal SK, Vallurupalli S, Al-Hawwas M, Hasan R, Miller K, Hakeem A. Prospective Evaluation of the Strategy of Functionally Optimized Coronary Intervention. J Am Heart Assoc. 2020 02 04; 9(3):e015073.
    View in: PubMed
    Score: 0.007
  14. Khan R, Al-Hawwas M, Hatem R, Azzalini L, Fortier A, Joliecoeur EM, Tanguay JF, Lavoie-L'Allier P, Ly HQ. Prognostic impact of the residual SYNTAX score on in-hospital outcomes in patients undergoing primary percutaneous coronary intervention. Catheter Cardiovasc Interv. 2016 Nov; 88(5):740-747.
    View in: PubMed
    Score: 0.006
  15. Azzalini L, Al-Hawwas M, L'Allier PL. Very late bioresorbable vascular scaffold thrombosis: a new clinical entity. EuroIntervention. 2015 May 19; 11(1):e1-2.
    View in: PubMed
    Score: 0.005
  16. Azzalini L, Khan R, Al-Hawwas M, Hatem R, Fortier A, L'Allier PL, Ly HQ. Effect of radial-to-femoral access crossover on adverse outcomes in primary percutaneous coronary intervention. Am J Cardiol. 2014 Oct 15; 114(8):1165-73.
    View in: PubMed
    Score: 0.005
  17. Marmagkiolis K, Hakeem A, Choksi N, Al-Hawwas M, Edupuganti MM, Leesar MA, Cilingiroglu M. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty. Catheter Cardiovasc Interv. 2014 Oct 01; 84(4):555-64.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.